Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic. - Wikidata - wikimedia - TriplyDB

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

http://www.wikidata.org/entity/Q35541320

about

Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled Compounds Concentrations of oral lomefloxacin in serum and bronchial mucosa.Pulmonary disposition of antimicrobial agents: methodological considerations.Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance Delivering antibacterials to the lungs: considerations for optimizing outcomes.Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients.Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.Effect of macrolide antibiotics on macrophage functions.Antibiotic penetration into lung tissues.Genitourinary chlamydial infection: a reappraisal and hypothesis.Influence of cytostatic treatment on the efficacy of erythromycin and roxithromycin in a staphylococcal infection in mice.Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid.Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.High-Performance Liquid Chromatographic Determination of Roxithromycin in Tablets

P2860

Q26738341-B10D8282-1A35-4233-B0AE-EE2AC1705B22 Q35258597-C2E39788-8C39-49CD-8F06-0C3925862FC1 Q35447413-1CD3D8AD-7CD9-4986-A1AF-35A88B4CF1DF Q35447443-8364C5B9-8CA5-4CE2-8D80-3F7FD2893027 Q35627814-611BE0C6-C4F0-43BF-961B-1F932B5F4ADE Q35808723-7D6724BE-BBBC-4A22-BB8D-7AD217264343 Q36757699-71C5F4B2-23ED-4F54-A031-6B103DBA6ADD Q37927017-F26479B9-9E26-49FA-8DE4-2B81CAAEDE69 Q41247296-DA6D4D44-CBE6-4503-86EB-C0226B71A307 Q42417997-49290BC0-E99B-43BB-8510-24782C08EA7A Q43427569-FE0B8417-2534-4032-AC6C-8AB6CBA946B7 Q43755813-DF190E28-FAB6-4636-84A5-23DA2272AC09 Q44540492-2D388288-AC41-4D3E-A345-FF0DBA4F2D51 Q44869380-5878FC0B-4BDE-40A7-80FD-DF3660A4EC7E Q58309093-2E14AFDD-3B4A-4239-8297-621D92F7E8B6

P2860

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

http://www.wikidata.org/entity/Q35541320

description

1987 nî lūn-bûn

@nan

1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

@ast

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

@en

type

label

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

@ast

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

@en

prefLabel

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

@ast

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

@en

P1433

Q35541320-FB3511F3-2867-4891-A806-0E5C967ED90C

P1476

Q35541320-0A5BA99C-D81C-4909-9D04-33BA730D59E8

P2093

Q35541320-18E4EADE-4A30-4A46-8CEF-2D0C6173821D

Q35541320-19B49434-3F2F-433C-BDAF-8793C2DDFA29

Q35541320-318E86C5-0F89-45AC-B3E3-9FCD16958758

Q35541320-5537EF02-68E2-45A3-9DC2-387F94B4E6B3

Q35541320-5CE85A1E-7ABF-44BB-82DF-1878FFCAD699

Q35541320-9DC865C9-BBAD-41BE-A5F1-3128E956DE31

Q35541320-A90C9059-9650-4480-9B63-161C4F2E1A13

Q35541320-BE022751-457E-49CD-8AD1-948470E0C5DB

P2860

Q35541320-04020004-6EEE-4D23-AB6D-636B03DCEE63

Q35541320-184C8489-C58F-44A4-A450-6CD06CAC141B

Q35541320-23CC1829-F55B-466B-A0F5-78A0CEF605FB

Q35541320-2BB240D7-A0B2-494A-8AA8-B56C2F877BE8

Q35541320-30ECC280-AECD-40B8-826D-FD5EE1581E4C

Q35541320-3E2A153F-BD10-42BC-B24B-802AA24EBB95

Q35541320-5692E195-061C-4D10-A587-FC1FDDD4AF62

Q35541320-68CB0FDE-74C9-431D-9370-B56DA5902EBE

Q35541320-9A9E619A-D177-481E-8ADF-7A71663860E9

Q35541320-9ACC7D69-4EF5-4AD8-AA1B-DAA9B9098CA6

P304

Q35541320-8C7B627B-2824-471E-803F-41BA118EB3F8

P31

Q35541320-94EF705E-0656-43CE-ADE9-97FFEE929376

P356

Q35541320-73910D62-B72D-477F-9290-56227E7E72A8

P407

Q35541320-92F3E8A5-F1F0-49A3-8E14-CF5162A21EB3

P433

Q35541320-44B0BBEF-7951-460A-948F-5A3448B65C27

P478

Q35541320-7D86FAFA-09A0-4FA3-B2A0-0EFE7FE58455

P577

Q35541320-CB1D8641-F5D2-4717-B321-ACFDCD7F8954

P5875

Q35541320-2FDE4E43-D305-4CFC-8856-73BE73D2D984

P698

Q35541320-88F25707-80C8-4854-A9C1-81FED53A75F2

P932

Q35541320-953722CD-AC36-4D75-912F-DF3DE07E5868

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

@en

P2093

Basset G

http://www.w3.org/2001/XMLSchema#string

Brun P

http://www.w3.org/2001/XMLSchema#string

Chastre J

http://www.w3.org/2001/XMLSchema#string

Fourtillan JB

http://www.w3.org/2001/XMLSchema#string

Gibert C

http://www.w3.org/2001/XMLSchema#string

Manuel C

http://www.w3.org/2001/XMLSchema#string

Soler P

http://www.w3.org/2001/XMLSchema#string

Trouillet JL

http://www.w3.org/2001/XMLSchema#string

P2860

Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin

In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs

Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease

Membrane transport of clindamycin in alveolar macrophages.

Antibiotic entry into human polymorphonuclear leukocytes

Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium.

In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.

Transalveolar transport of large polar solutes (sucrose, inulin, and dextran).

P304

1312-1316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.31.9.1312

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1987-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19486778

http://www.w3.org/2001/XMLSchema#string

P698

3674843

http://www.w3.org/2001/XMLSchema#string

P932

174933

http://www.w3.org/2001/XMLSchema#string